FDA Adverse Event Injury Summary report: N

SUPERA BILIARY STENT DELIVERY SYSTEM

MDR report key: 1930712 · Received December 14, 2010

Report

Report Number
3005325609-2010-00019
Event Type
Injury
Date Received
December 14, 2010
Date of Event
September 22, 2010
Report Date
November 15, 2010
Manufacturer
IDEV TECHNOLOGIES, INC.
Product Code
FGE
PMA / PMN Number
K071646
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE CAUSE OF THE EVENT IS UNK. NO INDICATION OF A DEVICE MALFUNCTION. THE CAUSE IS LIKELY THE PT'S DISEASE PROGRESSION.

Description of Event or Problem · 1

THE PT IS CURRENTLY ENROLLED IN THE (B)(6). AT 17 MONTHS POST IMPLANT THE PT WAS ADMITTED FOR INVASIVE DIAGNOSTIC TESTING OF SIGNIFICANT STENOSIS OF BOTH SUPERFICIAL FEMORAL ARTERIES AS PART OF A CONTINUED ANGIOLOGICAL TREATMENT FOR ARTERIAL OCCLUSIVE DISEASE, STAGE IIB. INTERVENTION INCLUDED PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) OF THE IN-STENT STENOSIS. FOLLOWING PTA, ANGIOGRAPHIC RESULTS WERE "VERY GOOD." THE CAUSE OF THE RESTENOSIS IS UNK; THERE IS NO INDICATION OF A DEVICE MALFUNCTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SUPERA BILIARY STENT DELIVERY SYSTEM FGE IDEV TECHNOLOGIES, INC. SE-06-060-120-G2 302041

Patients

Seq Age Sex Outcome Treatment
1 81 YR Hospitalization| R